FDA approves Zaltrap
13:46 EDT 3 Aug 2012 | BioCentury
FDA approved a BLA from Sanofi (Euronext:SAN; NYSE:SNY) for Zaltrap ziv-aflibercept in combination with FOLFIRI chemotherapy to treat metastatic colorectal cancer (mCRC) that is resistant to or has progressed following an oxaliplatin-containing regim..
Original Article: FDA approves Zaltrap
More From BioPortfolio on "FDA approves Zaltrap"
Biotech & Healthcare Channels
World News
Life Science Events
Corporate Database
Market Reports
Categories
Search BioPortfolio:
